Upcoming Events Webinars
with TRI
Embark on a journey to unleash the full capabilities of Risk-Based Quality Management (RBQM) by joining TRI at forthcoming industry gatherings and participating in our specialized webinars led by seasoned experts.
CONFERENCE
SCOPE Summit for ClinOps Execs Europe
-
InterContinental, Barcelona, Spain
-
October 29-30, 2024
WEBINAR
Cost Savings and Quality? Making the Case for RBQM
With Macarena Sahores, Senior RBQM Operations Consultant, TRI.
-
Virtual event
-
October 24, 2024
WEBINAR
RBQM Basics: Benefits of Centralized Monitoring
With Isabel Villanueva, Senior RBQM Operations Consultant, TRI.
-
Virtual event
-
December 5, 2024
TESTIMONIALS
RBQM Success Stories
Hear directly from our partners about how we've helped them.
What truly set TriTrials apart from other vendors was their unparalleled commitment to a quality deliverable helping us effectively apply a novel approach to our operations. They achieved a deep understanding of our objectives by partnering with us on a rigorous change management process which culminated in a shared vision for the integration of their risk assessment and central monitoring solution.
The Worldwide Clinical Trials team is pleased with our continued partnership with TRI and we are excited about the milestone of having 150 clinical trials in TRI's Risk-Based Quality Management platform. This is a key benefit for our customers as it improves data quality, trial efficiency, and patient safety.
RBQM NEWS
Clinical trial quality news and views
Subscribe to get the latest RBQM insights sent to your mailbox.
Risk-Based Clinical Data Management Takes Center Stage at SCDM 2024
The Society for Clinical Data Management (SCDM) annual conference has always been a cornerstone for clinical data professionals, but this year’s event, held in Boston from September 30th to October…
The Quality Issue – September 2024
Welcome to this month’s Quality Issue, where we spotlight some of the most important developments in clinical research and Risk-Based Quality Management (RBQM). From transformative FDA guidance to our upcoming…
Inside the FDA’s Radical New Plan to Revolutionize Drug Development
The FDA has just released a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice Guidance for Industry” aimed at transforming how Randomized Controlled…